Skip to main content
Clinical Trials/NCT01492023
NCT01492023
Completed
Not Applicable

The Effects of Attention Retraining on Cognitive Performance, QoL and Perceived Cognitive Impairment in MS - a Single Blind, Randomized, Controlled Study

Finnish MS Society3 sites in 1 country97 target enrollmentNovember 2010

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Multiple Sclerosis
Sponsor
Finnish MS Society
Enrollment
97
Locations
3
Primary Endpoint
Subjective cognitive performance
Status
Completed
Last Updated
13 years ago

Overview

Brief Summary

The purpose of this study is to determine whether neuropsychological rehabilitation focused on attention retraining and teaching compensatory strategies has positive effects on cognitive performance, quality of life (QoL)and perceived cognitive deficits in patients with MS. The hypothesis is that the neuropsychological intervention shows positive effects on cognitive performance, QoL and perceived cognitive deficits.

Detailed Description

Background: Cognitive impairments are a typical manifestation of multiple sclerosis (MS). According to previous studies, neuropsychological rehabilitation may improve cognitive performance in MS. However, the quality of previous studies is low and, accordingly, the evidence on the effects of neuropsychological rehabilitation is low to modest. Objective: To study whether neuropsychological rehabilitation improves cognitive performance, QoL and perceived cognitive deficits in patients with MS. Methods: Altogether 100 patients with MS are randomised either to intervention or to control group in three different study sites. All the study subjects are assessed with neuropsychological tests as well as self-rating questionnaires evaluating mood, QoL, cognitive deficits, fatigue and impact of the disease at baseline, after three months (immediately after intervention) and after six months. Patients in the intervention group are offered with neuropsychological rehabilitation conducted once a week during thirteen weeks. Patients in the control group do not receive any intervention. Results: The effects of intervention on cognitive performance, QoL and perceived cognitive impairments are evaluated using appropriate statistical procedures and comparing the differences between the intervention and the control group. The present status: The baseline assessments have been performed and the intervention will be conducted between September and December, 2011.

Registry
clinicaltrials.gov
Start Date
November 2010
End Date
May 2012
Last Updated
13 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Finnish MS Society
Responsible Party
Principal Investigator
Principal Investigator

Paivi Hamalainen

neuropsychologist, adjunct professor

Finnish MS Society

Eligibility Criteria

Inclusion Criteria

  • clinically definite MS
  • EDSS \< 6
  • age 18-58 years
  • subjective cognitive problems and objective decline in attention

Exclusion Criteria

  • other neurological disease than MS
  • psychiatric diagnosis
  • severe depression
  • secondary progressive or primary progressive course of MS
  • alcohol or drug abuse
  • relapse during the preceding month of study entry
  • neuropsychological rehabilitation during the study
  • no subjective cognitive cognitive problems and /or no decline in attention
  • overall cognitive impairment (performance in all tests of BRBNT under -1.5 SD compared to norms of healthy controls)

Outcomes

Primary Outcomes

Subjective cognitive performance

Time Frame: six months

The effects of rehabilitation on subjective cognitive performance: perceived cognitive deficits (Perceived Deficits Questionnaire, PDQ)

Objective cognitive performance

Time Frame: six months

effects of rehabilitation on objective cognitive performance: SDMT

Goal achievement

Time Frame: six months

Goal achievement: Goal Attainment Scaling (GAS)

Secondary Outcomes

  • Mood(six months)
  • The impact of the disease(six months)
  • Subjective cognitive performance(six months)
  • Quality of life(six months)
  • Objective cognitive performance(six months)
  • Fatigue(six months)

Study Sites (3)

Loading locations...

Similar Trials